Aurora Cannabis (TSE:ACB) Stock Price Up 5.8% – Still a Buy?

Shares of Aurora Cannabis Inc. (TSE:ACB) traded up 5.8% on Tuesday. The stock traded as high as C$5.85 and last traded at C$5.81. 215,864 shares changed hands during mid-day trading, a decline of 47% from the average daily volume of 404,221 shares. The stock had previously closed at C$5.49.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Canaccord Genuity Group lowered their price target on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. BMO Capital Markets upgraded Aurora Cannabis to a “hold” rating in a report on Wednesday, August 5th. Finally, ATB Cormark Capital Markets boosted their target price on Aurora Cannabis from C$5.60 to C$7.00 and gave the stock a “tender” rating in a research report on Tuesday, October 6th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of C$6.67.

Aurora Cannabis Price Performance

The company has a quick ratio of 2.48, a current ratio of 5.36 and a debt-to-equity ratio of 4.30. The firm’s fifty day moving average price is C$5.65 and its two-hundred day moving average price is C$4.94. The stock has a market capitalization of C$359.97 million, a PE ratio of -2.99 and a beta of 0.64.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C($0.07) earnings per share for the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. The company had revenue of C$67.55 million for the quarter. On average, equities analysts predict that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

About Aurora Cannabis

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty’s ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.